The impact of lymph node ratio (LNR) on survival in colorectal cancer: a retrospective cohort study

Hüseyin Kocaaslan; Fatih Sümer

doi:10.47582/jompac.1860345

The impact of lymph node ratio (LNR) on survival in colorectal cancer: a retrospective cohort study

Abstract

Aims: This study aimed to investigate the prognostic value of the lymph node ratio (LNR) on survival in patients with colorectal cancer. Methods: After excluding patients with metastatic disease and those who underwent palliative surgery, a total of 211 patients who underwent curative surgical resection for colorectal cancer between 2013 and 2022 were retrospectively analyzed. LNR was calculated as the ratio of the number of metastatic lymph nodes to the total number of lymph nodes examined. Patients were stratified into four groups according to their LNR values: LNR=0, 00.2. Survival analyses were performed using the Kaplan–Meier method and Cox proportional hazards regression models. Results: Of the patients, 124 (59.0%) were male. The mean follow-up duration was 38.2±41.1 months. The mean number of harvested lymph nodes was 32.4±27.1, and the mean number of positive lymph nodes was 3.2±5.8. According to LNR classification, 132 patients (62.9%) had LNR=0, 38 (18.1%) had 00.2. In univariate Cox regression analysis, using LNR=0 as the reference category, the hazard ratio (HR) was 2.45 (95% CI: 1.32–4.55, p=0.004) for 00.2. Conclusion: LNR is a strong and independent predictor of survival in patients with colorectal cancer. Incorporating LNR into clinical practice may improve risk stratification and facilitate personalized treatment strategies.

Keywords

Supporting Institution

No funding

Ethical Statement

Ethical Declarations Ethics Committee Approval: This study was approved by the Inonu University Health Sciences Scientific Research Ethics Committee (Protocol No: 2025/8829). All patient data were anonymized in accordance with confidentiality rules. The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Informed Consent: Because the study was designed retrospectively, no written informed consent form was obtained from patients. Referee Evaluation Process: Externally peer-reviewed. Conflict of Interest Statement: The authors declare that they have no competing interests. Financial Disclosure: The authors declared that this study received no financial support. Author Contributions: All of the authors declare that they have all participated in the design, execution, and analysis of the paper, and they approved the final version.

References

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7-33. doi:10.3322/caac.21708
Benson AB, Venook AP, Al-Hawary MM, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329-359. doi:10.6004/jnccn.2021.0012
Liu Q, Huang M, Yang J, et al. Association between the number of retrieved lymph nodes and demographic/tumour-related characteristics in colorectal cancer: a systematic review and meta-analysis. BMJ Open. 2023;13(12):e072244. doi:10.1136/bmjopen-2023-072244
Yildirim F, Sezak M, Bozbiyik O, Gursoy P, Doganavsargil B. Clinicopathologic determinants of lymph node count and prognostic significance of metastatic lymph node ratio in colorectal cancer. Diagnostics. 2025;15(23):2962. doi:10.3390/diagnostics15232962
Pyo JS, Kim JH, Lee SY, Baek TH, Kang DW. Metastatic lymph node ratio (mLNR) is a useful parameter in the prognosis of colorectal cancer: a meta-analysis for the prognostic role of mLNR. Medicina. 2019;55(10): 673. doi:10.3390/medicina55100673
Kang JS, Higuchi R, He J, et al. Proposal of the minimal number of retrieved regional lymph nodes for accurate staging of distal bile duct cancer and clinical validation of the three-tier lymph node staging system (AJCC 8th edition). J Hepatobiliary Pancreat Sci. 2020;27(2):75-83. doi:10.1002/jhbp.706
Mroczkowski P, Kim S, Otto R, et al. Prognostic value of metastatic lymph node ratio and identification of factors influencing the lymph node yield in patients undergoing curative colon cancer resection. Cancers (Basel). 2024;16(1):218. doi:10.3390/cancers16010218
Wang J, Hassett JM, Dayton MT, Kulaylat MN. The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg. 2008;12(10):1790-1796. doi:10.1007/s11605-008-0631-3

Aslan O, Topcu R, Sezikli İ, Yüksek MA, Perçem AK, Uğur F. Prognostic value of metastatic lymph node ratio and its effect on disease-free survival in colon cancer. Front Oncol. 2025;15:1624798. doi:10.3389/fonc.2025.1624798
Occhionorelli S, Andreotti D, Vallese P, et al. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery. World J Surg Oncol. 2018;16:186. doi:10.1186/s12957-018-1486-0
Elbaiomy M, Waheed A, Elkhodary T. Prognostic value of lymph node ratio in lymph node-invaded colon cancer. Ann Oncol. 2019;30(Suppl 4): iv34. doi:10.1093/annonc/mdz155.122
Parnaby CN, Scott NW, Ramsay G, et al. Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection. Br J Cancer. 2015;113(2): 212–219. doi:10.1038/bjc.2015.211
Chen SL, Steele SR, Eberhardt J, et al. Lymph node ratio as a quality and prognostic indicator in stage III colon cancer. Ann Surg. 2011;253(1):82-87. doi:10.1097/SLA.0b013e3181f9c846
Wang J, Kulaylat M, Rockette H, et al. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Ann Surg. 2009;249(4):559-563. doi:10.1097/SLA.0b013e31819ed6c5
Yang Y, Wang Y, Wang Z. Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: a validation study. Front Surg. 2022;9:929576. doi:10.3389/fsurg.2022.929576
Derici ST, Ergenç M, Sücüllü İ, Akın ML. Prognostic role of the lymph node ratio in colorectal cancer: a retrospective study. World J Colorectal Surg. 2022;11:94-100. doi:10.5005/jp-journals-10030-1395
Karjol U, Jonnada P, Chandranath A, Cherukuru S. Lymph node ratio as a prognostic marker in rectal cancer survival: a systematic review and meta-analysis. Cureus. 2020;12(5):e8047. doi:10.7759/cureus.8047
Beirat AF, Amarin JZ, Suradi HH, et al. Lymph node ratio is a more robust predictor of overall survival than N stage in stage III colorectal adenocarcinoma. Diagn Pathol. 2024;19(1):44. doi:10.1186/s13000-024-01484-2
Xie D, Song X, Tong L. Stage migration resulting from inadequate number of examined lymph nodes impacts prognosis in stage II colon cancer after radical surgery. Int J Colorectal Dis. 2021;36(5):959-969. doi: 10.1007/s00384-020-03792-9
Vather R, Sammour T, Kahokehr A, Connolly AB, Hill AG. Lymph node evaluation and long-term survival in stage II and stage III colon cancer: a national study. Ann Surg Oncol. 2009;16(3):585-593. doi:10.1245/s10434-008-0265-8
Duraker N, Çaynak Z, Hot S. The prognostic value of lymph node ratio in patients with node-positive colorectal cancer. Turk J Colorectal Dis. 2017;27:76-83. doi:10.4274/tjcd.83435
Hai ZX, Peng D, Li ZW, et al. The effect of lymph node ratio on the surgical outcomes in patients with colorectal cancer. Sci Rep. 2024;14: 17689. doi:10.1038/s41598-024-17689-7
Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97(3):219-225. doi:10.1093/jnci/dji020

Details

Primary Language

English

Subjects

Gastroenterology Surgery, General Surgery

Journal Section

Research Article

Authors

Hüseyin Kocaaslan ^*
0000-0002-4590-4850
Türkiye

Fatih Sümer
0000-0002-0557-1369
Türkiye

Publication Date

February 20, 2026

Submission Date

January 9, 2026

Acceptance Date

February 2, 2026

Published in Issue

Year 2026 Volume: 7 Number: 1

DOI

https://doi.org/10.47582/jompac.1860345

IZ

https://izlik.org/JA75FX57GY

Cite

RIS / Bibtex

APA

Kocaaslan, H., & Sümer, F. (2026). The impact of lymph node ratio (LNR) on survival in colorectal cancer: a retrospective cohort study. Journal of Medicine and Palliative Care, 7(1), 108-113. https://doi.org/10.47582/jompac.1860345

AMA

1.Kocaaslan H, Sümer F. The impact of lymph node ratio (LNR) on survival in colorectal cancer: a retrospective cohort study. J Med Palliat Care / JOMPAC / jompac. 2026;7(1):108-113. doi:10.47582/jompac.1860345

Chicago

Kocaaslan, Hüseyin, and Fatih Sümer. 2026. “The Impact of Lymph Node Ratio (LNR) on Survival in Colorectal Cancer: A Retrospective Cohort Study”. Journal of Medicine and Palliative Care 7 (1): 108-13. https://doi.org/10.47582/jompac.1860345.

EndNote

Kocaaslan H, Sümer F (February 1, 2026) The impact of lymph node ratio (LNR) on survival in colorectal cancer: a retrospective cohort study. Journal of Medicine and Palliative Care 7 1 108–113.

IEEE

[1]H. Kocaaslan and F. Sümer, “The impact of lymph node ratio (LNR) on survival in colorectal cancer: a retrospective cohort study”, J Med Palliat Care / JOMPAC / jompac, vol. 7, no. 1, pp. 108–113, Feb. 2026, doi: 10.47582/jompac.1860345.

ISNAD

Kocaaslan, Hüseyin - Sümer, Fatih. “The Impact of Lymph Node Ratio (LNR) on Survival in Colorectal Cancer: A Retrospective Cohort Study”. Journal of Medicine and Palliative Care 7/1 (February 1, 2026): 108-113. https://doi.org/10.47582/jompac.1860345.

JAMA

1.Kocaaslan H, Sümer F. The impact of lymph node ratio (LNR) on survival in colorectal cancer: a retrospective cohort study. J Med Palliat Care / JOMPAC / jompac. 2026;7:108–113.

MLA

Kocaaslan, Hüseyin, and Fatih Sümer. “The Impact of Lymph Node Ratio (LNR) on Survival in Colorectal Cancer: A Retrospective Cohort Study”. Journal of Medicine and Palliative Care, vol. 7, no. 1, Feb. 2026, pp. 108-13, doi:10.47582/jompac.1860345.

Vancouver

1.Hüseyin Kocaaslan, Fatih Sümer. The impact of lymph node ratio (LNR) on survival in colorectal cancer: a retrospective cohort study. J Med Palliat Care / JOMPAC / jompac. 2026 Feb. 1;7(1):108-13. doi:10.47582/jompac.1860345